Compositions and methods relating to glucagon receptor antibodies
US8158759B2 · kind B2 · utility
13Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2011 |
| Grant date | Apr 17, 2012 |
| Priority date | — |
| Expiry date | May 23, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies which specifically bind to the human glucagon receptor. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies including methods of treating and preventing type 2 diabetes and related disorders by administering such antibodies to a subject in need of such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.